Sparreboom, Alex <br/><br/>
Effect of ABCG2 genotype on the oral bioavailability of topotecan.  [electronic resource] 

 -  Cancer biology & therapy  Jun 2005 
 - 650-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1538-4047 
<br/><br/><label>Standard No.: </label>10.4161/cbt.4.6.1731  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily G, Member 2<br/>ATP-Binding Cassette Transporters--genetics<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Amino Acid Substitution<br/>Antineoplastic Agents--administration & dosage<br/>Biological Availability<br/>Carcinoma, Small Cell--genetics<br/>DNA, Neoplasm--genetics<br/>Female<br/>Gene Frequency<br/>Genotype<br/>Heterozygote<br/>Humans<br/>Lung Neoplasms--genetics<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--genetics<br/>Ovarian Neoplasms--genetics<br/>Pharmacogenetics<br/>Pilot Projects<br/>Polymorphism, Single Nucleotide<br/>Prospective Studies<br/>Topotecan--administration & dosage<br/>Tumor Cells, Cultured